Trial Outcomes & Findings for A Direct-to-patient Intervention to Increase Rates of Osteoporosis Care (NCT NCT01907269)

NCT ID: NCT01907269

Last Updated: 2018-06-26

Results Overview

We will assess the number of participants that self-report the initiation of an osteoporosis prescription medication. It will be assessed using a self-completed survey. Osteoporosis prescription medications that will be assessed include: alendronate, calcitonin, denosumab ibandronate, raloxifene, risedronate, teriparatide, and zoledronic acid. We will not include initiation of estrogen hormone therapies as part of the primary outcome.

Recruitment status

COMPLETED

Study phase

NA

Target enrollment

2684 participants

Primary outcome timeframe

6 months post-intervention

Results posted on

2018-06-26

Participant Flow

Participant milestones

Participant milestones
Measure
Video-based Intervention
Video-based intervention providing personalized feedback regarding patients' risk of subsequent fractures, customized information regarding osteoporosis care, and messaging to activate patients to become more engaged in improving osteoporosis treatment and doctor-patient communication. This novel content will use "story-telling" delivered via the Internet and DVDs. The content will be uniquely tailored to each person based on their reported barriers to care, age and race/ethnicity. The video-based intervention materials will be augmented by a personal phone call and interactive voice response messaging. Video-based Intervention: Video clips delivered by DVD and Internet
Usual Care
6 Month Outcome Measures Post-interventi
STARTED
1342
1342
6 Month Outcome Measures Post-interventi
COMPLETED
953
1053
6 Month Outcome Measures Post-interventi
NOT COMPLETED
389
289
18 Month Outcome Measures Post-intervent
STARTED
1178
1250
18 Month Outcome Measures Post-intervent
COMPLETED
859
970
18 Month Outcome Measures Post-intervent
NOT COMPLETED
319
280

Reasons for withdrawal

Withdrawal data not reported

Baseline Characteristics

Data were only evaluated for intervention tailoring on the "Video-based intervention" arm. "Usual care" data on this measure was not evaluated for the purposes of tailoring, therefore the Row population consists only of the intervention arm (n=1342) and does not include usual care. This results in the row population differing from overall.

Baseline characteristics by cohort

Baseline characteristics by cohort
Measure
Video-based Intervention
n=1342 Participants
Video-based intervention providing personalized feedback regarding patients' risk of subsequent fractures, customized information regarding osteoporosis care, and messaging to activate patients to become more engaged in improving osteoporosis treatment and doctor-patient communication. This novel content will use "story-telling" delivered via the Internet and DVDs. The content will be uniquely tailored to each person based on their reported barriers to care, age and race/ethnicity. The video-based intervention materials will be augmented by a personal phone call and interactive voice response messaging. Video-based Intervention: Video clips delivered by DVD and Internet
Usual Care
n=1342 Participants
Total
n=2684 Participants
Total of all reporting groups
Age, Continuous
74.9 years
STANDARD_DEVIATION 8 • n=1342 Participants
74.9 years
STANDARD_DEVIATION 7.9 • n=1342 Participants
74.9 years
STANDARD_DEVIATION 7.96 • n=2684 Participants
Sex: Female, Male
Female
1342 Participants
n=1342 Participants
1342 Participants
n=1342 Participants
2684 Participants
n=2684 Participants
Sex: Female, Male
Male
0 Participants
n=1342 Participants
0 Participants
n=1342 Participants
0 Participants
n=2684 Participants
Ethnicity (NIH/OMB)
Hispanic or Latino
25 Participants
n=1342 Participants
21 Participants
n=1342 Participants
46 Participants
n=2684 Participants
Ethnicity (NIH/OMB)
Not Hispanic or Latino
1317 Participants
n=1342 Participants
1321 Participants
n=1342 Participants
2638 Participants
n=2684 Participants
Ethnicity (NIH/OMB)
Unknown or Not Reported
0 Participants
n=1342 Participants
0 Participants
n=1342 Participants
0 Participants
n=2684 Participants
Race (NIH/OMB)
American Indian or Alaska Native
0 Participants
n=1342 Participants
0 Participants
n=1342 Participants
0 Participants
n=2684 Participants
Race (NIH/OMB)
Asian
13 Participants
n=1342 Participants
13 Participants
n=1342 Participants
26 Participants
n=2684 Participants
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
0 Participants
n=1342 Participants
0 Participants
n=1342 Participants
0 Participants
n=2684 Participants
Race (NIH/OMB)
Black or African American
46 Participants
n=1342 Participants
52 Participants
n=1342 Participants
98 Participants
n=2684 Participants
Race (NIH/OMB)
White
1247 Participants
n=1342 Participants
1239 Participants
n=1342 Participants
2486 Participants
n=2684 Participants
Race (NIH/OMB)
More than one race
0 Participants
n=1342 Participants
0 Participants
n=1342 Participants
0 Participants
n=2684 Participants
Race (NIH/OMB)
Unknown or Not Reported
36 Participants
n=1342 Participants
38 Participants
n=1342 Participants
74 Participants
n=2684 Participants
Region of Enrollment
United States
1342 Participants
n=1342 Participants
1342 Participants
n=1342 Participants
2684 Participants
n=2684 Participants
Number of Participants who Completed Barriers to Osteoporosis Treatment
482 Participants
n=1342 Participants • Data were only evaluated for intervention tailoring on the "Video-based intervention" arm. "Usual care" data on this measure was not evaluated for the purposes of tailoring, therefore the Row population consists only of the intervention arm (n=1342) and does not include usual care. This results in the row population differing from overall.
0 Participants
Data were only evaluated for intervention tailoring on the "Video-based intervention" arm. "Usual care" data on this measure was not evaluated for the purposes of tailoring, therefore the Row population consists only of the intervention arm (n=1342) and does not include usual care. This results in the row population differing from overall.
482 Participants
n=1342 Participants • Data were only evaluated for intervention tailoring on the "Video-based intervention" arm. "Usual care" data on this measure was not evaluated for the purposes of tailoring, therefore the Row population consists only of the intervention arm (n=1342) and does not include usual care. This results in the row population differing from overall.
Number of Participants who completed Patient's Views about Osteoporosis and Use of Therapy Scale
429 Participants
n=1342 Participants • Data were only evaluated for intervention tailoring on the "Video-based intervention" arm. "Usual care" data on this measure was not evaluated for the purposes of tailoring, therefore the Row population consists only of the intervention arm (n=1342) and does not include usual care. This results in the row population differing from overall.
0 Participants
Data were only evaluated for intervention tailoring on the "Video-based intervention" arm. "Usual care" data on this measure was not evaluated for the purposes of tailoring, therefore the Row population consists only of the intervention arm (n=1342) and does not include usual care. This results in the row population differing from overall.
429 Participants
n=1342 Participants • Data were only evaluated for intervention tailoring on the "Video-based intervention" arm. "Usual care" data on this measure was not evaluated for the purposes of tailoring, therefore the Row population consists only of the intervention arm (n=1342) and does not include usual care. This results in the row population differing from overall.
Number of Participants who Completed Readiness to Behavior Change
300 Participants
n=1342 Participants • Data were only evaluated for intervention tailoring on the "Video-based intervention" arm. "Usual care" data on this measure was not evaluated for the purposes of tailoring, therefore the Row population consists only of the intervention arm (n=1342) and does not include usual care. This results in the row population differing from overall.
0 Participants
Data were only evaluated for intervention tailoring on the "Video-based intervention" arm. "Usual care" data on this measure was not evaluated for the purposes of tailoring, therefore the Row population consists only of the intervention arm (n=1342) and does not include usual care. This results in the row population differing from overall.
300 Participants
n=1342 Participants • Data were only evaluated for intervention tailoring on the "Video-based intervention" arm. "Usual care" data on this measure was not evaluated for the purposes of tailoring, therefore the Row population consists only of the intervention arm (n=1342) and does not include usual care. This results in the row population differing from overall.
Number of Participants who Completed the Osteoporosis Treatment History (tailoring)
131 Participants
n=1342 Participants • Data were only evaluated for intervention tailoring on the "Video-based intervention" arm. "Usual care" data on this measure was not evaluated for the purposes of tailoring, therefore the Row population consists only of the intervention arm (n=1342) and does not include usual care. This results in the row population differing from overall.
0 Participants
Data were only evaluated for intervention tailoring on the "Video-based intervention" arm. "Usual care" data on this measure was not evaluated for the purposes of tailoring, therefore the Row population consists only of the intervention arm (n=1342) and does not include usual care. This results in the row population differing from overall.
131 Participants
n=1342 Participants • Data were only evaluated for intervention tailoring on the "Video-based intervention" arm. "Usual care" data on this measure was not evaluated for the purposes of tailoring, therefore the Row population consists only of the intervention arm (n=1342) and does not include usual care. This results in the row population differing from overall.

PRIMARY outcome

Timeframe: 6 months post-intervention

Population: For the Intent-to-Treat Analysis the data was imputed for non-responders.

We will assess the number of participants that self-report the initiation of an osteoporosis prescription medication. It will be assessed using a self-completed survey. Osteoporosis prescription medications that will be assessed include: alendronate, calcitonin, denosumab ibandronate, raloxifene, risedronate, teriparatide, and zoledronic acid. We will not include initiation of estrogen hormone therapies as part of the primary outcome.

Outcome measures

Outcome measures
Measure
Video-based Intervention
n=1342 Participants
Video-based intervention providing personalized feedback regarding patients' risk of subsequent fractures, customized information regarding osteoporosis care, and messaging to activate patients to become more engaged in improving osteoporosis treatment and doctor-patient communication. This novel content will use "story-telling" delivered via the Internet and DVDs. The content will be uniquely tailored to each person based on their reported barriers to care, age and race/ethnicity. The video-based intervention materials will be augmented by a personal phone call and interactive voice response messaging. Video-based Intervention: Video clips delivered by DVD and Internet
Usual Care
n=1342 Participants
Number of Participants That Initiate an Osteoporosis Prescription Medication
157 Participants
153 Participants

SECONDARY outcome

Timeframe: 6 and 18 months post-intervention

Population: For the Intent-to-Treat Analysis the data was imputed for non-responders.

We will assess the use of calcium and vitamin D by participant. This will be assessed on a self-completed survey. Participants will be asked if they are currently taking a calcium supplement and/or vitamin D supplement.

Outcome measures

Outcome measures
Measure
Video-based Intervention
n=1342 Participants
Video-based intervention providing personalized feedback regarding patients' risk of subsequent fractures, customized information regarding osteoporosis care, and messaging to activate patients to become more engaged in improving osteoporosis treatment and doctor-patient communication. This novel content will use "story-telling" delivered via the Internet and DVDs. The content will be uniquely tailored to each person based on their reported barriers to care, age and race/ethnicity. The video-based intervention materials will be augmented by a personal phone call and interactive voice response messaging. Video-based Intervention: Video clips delivered by DVD and Internet
Usual Care
n=1342 Participants
Number of Participants Who Reported Use of Calcium and Vitamin D
Vitamin D (6 months)
554 Participants
562 Participants
Number of Participants Who Reported Use of Calcium and Vitamin D
Calcium (6 months)
427 Participants
437 Participants
Number of Participants Who Reported Use of Calcium and Vitamin D
Vitamin D (18 months)
475 Participants
572 Participants
Number of Participants Who Reported Use of Calcium and Vitamin D
Calcium (18 months)
249 Participants
310 Participants

SECONDARY outcome

Timeframe: 6 and 18 months post-intervention

Population: For the Intent-to-Treat Analysis the data was imputed for non-responders. Surveys for BMD (18 months) included 3 responses. If participants marked option (2) that they had received a BMD, but \> 12 months ago they were excluded from analyses. Thus our overall population analyzed (those marking response 1 or 3) is different than our participant flow.

Self-report of a receipt of a DXA scan (Bone Mineral Density test).

Outcome measures

Outcome measures
Measure
Video-based Intervention
n=1342 Participants
Video-based intervention providing personalized feedback regarding patients' risk of subsequent fractures, customized information regarding osteoporosis care, and messaging to activate patients to become more engaged in improving osteoporosis treatment and doctor-patient communication. This novel content will use "story-telling" delivered via the Internet and DVDs. The content will be uniquely tailored to each person based on their reported barriers to care, age and race/ethnicity. The video-based intervention materials will be augmented by a personal phone call and interactive voice response messaging. Video-based Intervention: Video clips delivered by DVD and Internet
Usual Care
n=1342 Participants
Number of Participants Who Reported Receipt of Bone Mineral Density (BMD) Testing
BMD (6 months)
290 Participants
268 Participants
Number of Participants Who Reported Receipt of Bone Mineral Density (BMD) Testing
BMD (18 months)
530 Participants
522 Participants

SECONDARY outcome

Timeframe: 18 months

We will assess the number of participants that self-report the initiation of an osteoporosis prescription medication. It will be assessed using a self-completed survey. Osteoporosis prescription medications that will be assessed include: alendronate, calcitonin, denosumab ibandronate, raloxifene, risedronate, teriparatide, and zoledronic acid. We will not include initiation of estrogen hormone therapies as part of the outcome.

Outcome measures

Outcome measures
Measure
Video-based Intervention
n=1178 Participants
Video-based intervention providing personalized feedback regarding patients' risk of subsequent fractures, customized information regarding osteoporosis care, and messaging to activate patients to become more engaged in improving osteoporosis treatment and doctor-patient communication. This novel content will use "story-telling" delivered via the Internet and DVDs. The content will be uniquely tailored to each person based on their reported barriers to care, age and race/ethnicity. The video-based intervention materials will be augmented by a personal phone call and interactive voice response messaging. Video-based Intervention: Video clips delivered by DVD and Internet
Usual Care
n=1250 Participants
Number of Participants That Initiate an Osteoporosis Prescription Medication
136 Participants
131 Participants

OTHER_PRE_SPECIFIED outcome

Timeframe: 6 and 18 months post-intervention

Population: For the Intent-to-Treat Analysis the data was imputed for non-responders.

Outcome measures

Outcome measures
Measure
Video-based Intervention
n=1342 Participants
Video-based intervention providing personalized feedback regarding patients' risk of subsequent fractures, customized information regarding osteoporosis care, and messaging to activate patients to become more engaged in improving osteoporosis treatment and doctor-patient communication. This novel content will use "story-telling" delivered via the Internet and DVDs. The content will be uniquely tailored to each person based on their reported barriers to care, age and race/ethnicity. The video-based intervention materials will be augmented by a personal phone call and interactive voice response messaging. Video-based Intervention: Video clips delivered by DVD and Internet
Usual Care
n=1342 Participants
Number of Participants Who Reported Communicating With a Health Care Provider About Osteoporosis Care
Bone health discussion w/provider (6 months)
583 Participants
573 Participants
Number of Participants Who Reported Communicating With a Health Care Provider About Osteoporosis Care
Bone health discussion w/provider (18 months)
779 Participants
806 Participants

Adverse Events

Video-based Intervention

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Usual Care

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Serious adverse events

Adverse event data not reported

Other adverse events

Adverse event data not reported

Additional Information

Dr. Elizabeth J. Rahn

University of Alabama at Birmingham

Phone: 2059966552

Results disclosure agreements

  • Principal investigator is a sponsor employee
  • Publication restrictions are in place